Issued Patents All Time
Showing 25 most recent of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11998545 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more | 2024-06-04 |
| 11970485 | RET kinase inhibitors | Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski, Thomas Combs IRVIN +9 more | 2024-04-30 |
| 11964968 | Compounds useful for inhibiting RET kinase | Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Thomas Combs IRVIN, Manoj KUMAR +4 more | 2024-04-23 |
| 11964988 | Fused heterocyclic compounds as RET kinase inhibitors | James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Dean Russell Kahn +9 more | 2024-04-23 |
| 11878970 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Xiaohong Chen, Surendra DAWADI +12 more | 2024-01-23 |
| 11873295 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Surendra DAWADI, Eugene Richard Hickey +13 more | 2024-01-16 |
| 11851434 | Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors | Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, David A. Moreno +2 more | 2023-12-26 |
| 11807651 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile | Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more | 2023-11-07 |
| 11697647 | RET kinase inhibitors | Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski, Thomas Combs IRVIN +9 more | 2023-07-11 |
| 11649227 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Markus Dahlgren, Shulu FENG +16 more | 2023-05-16 |
| 11648243 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more | 2023-05-16 |
| 11613533 | Compounds useful for inhibiting RET kinase | Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Thomas Combs IRVIN, Manoj KUMAR +4 more | 2023-03-28 |
| 11603374 | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors | James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Elizabeth A. McFaddin +6 more | 2023-03-14 |
| 11524963 | Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors | James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Andrew T. Metcalf +3 more | 2022-12-13 |
| 11472802 | Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors | Shane M. Walls, Li Ren, Ginelle A. Ramann, David A. Moreno, Andrew T. Metcalf +6 more | 2022-10-18 |
| 11168090 | Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors | Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, David A. Moreno +2 more | 2021-11-09 |
| 11098064 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile | Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more | 2021-08-24 |
| 10966985 | Macrocyclic compounds as ROS1 kinase inhibitors | Steven W. Andrews, James F. Blake, Julia Haas | 2021-04-06 |
| 10953005 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more | 2021-03-23 |
| 10907215 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Nisha Nanda, Joshua H. Bilenker, James F. Blake, Barbara J. Brandhuber, Steven W. Andrews | 2021-02-02 |
| 10889589 | Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain | Shelley Allen, Steven W. Andrews, James F. Blake, Barbara J. Brandhuber, Julia Haas +4 more | 2021-01-12 |
| 10881652 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more | 2021-01-05 |
| 10851080 | Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds | Shelley Allen, Barbara J. Brandhuber, Timothy Kercher, Shannon L. Winski | 2020-12-01 |
| 10745419 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile | Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more | 2020-08-18 |
| 10724102 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Nisha Nanda, Joshua H. Bilenker, James F. Blake, Barbara J. Brandhuber, Steven W. Andrews | 2020-07-28 |